PB2308: QUALITY OF LIFE AND CLINICAL OUTCOMES IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) DURING TREATMENT WITH ROMIPLOSTIM IN A REAL-WORLD SETTING

Bibliographic Details
Main Authors: T. Ionova, O. Vinogradova, E. Markova, L. Mukha, N. Novitskaya, M. Pankrashkina, T. Shelekhova, D. Sherstnev, A. Proydakov, E. Lyurova, T. Pospelova, T. Babaeva, N. Bulieva, G. Kuchma, E. Andreevskaya, M. Frolova, E. Zinina, K. Trizna, I. Shestopalova, T. Shneyder, L. Khvorostenko, A. Kuchin, I. Mulina, S. Volkova, S. Zakharov, N. Porfirieva, T. Nikitina, S. Gritsaev
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000852060.15771.ed
_version_ 1797285895092568064
author T. Ionova
O. Vinogradova
E. Markova
L. Mukha
N. Novitskaya
M. Pankrashkina
T. Shelekhova
D. Sherstnev
A. Proydakov
E. Lyurova
T. Pospelova
T. Babaeva
N. Bulieva
G. Kuchma
E. Andreevskaya
M. Frolova
E. Zinina
K. Trizna
I. Shestopalova
T. Shneyder
L. Khvorostenko
A. Kuchin
I. Mulina
S. Volkova
S. Zakharov
N. Porfirieva
T. Nikitina
S. Gritsaev
author_facet T. Ionova
O. Vinogradova
E. Markova
L. Mukha
N. Novitskaya
M. Pankrashkina
T. Shelekhova
D. Sherstnev
A. Proydakov
E. Lyurova
T. Pospelova
T. Babaeva
N. Bulieva
G. Kuchma
E. Andreevskaya
M. Frolova
E. Zinina
K. Trizna
I. Shestopalova
T. Shneyder
L. Khvorostenko
A. Kuchin
I. Mulina
S. Volkova
S. Zakharov
N. Porfirieva
T. Nikitina
S. Gritsaev
author_sort T. Ionova
collection DOAJ
first_indexed 2024-03-07T18:10:02Z
format Article
id doaj.art-d114c42007ff41579575992848b0761e
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T18:10:02Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-d114c42007ff41579575992848b0761e2024-03-02T07:47:32ZengWileyHemaSphere2572-92412022-06-0162178217910.1097/01.HS9.0000852060.15771.ed202206003-02178PB2308: QUALITY OF LIFE AND CLINICAL OUTCOMES IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) DURING TREATMENT WITH ROMIPLOSTIM IN A REAL-WORLD SETTINGT. Ionova0O. Vinogradova1E. Markova2L. Mukha3N. Novitskaya4M. Pankrashkina5T. Shelekhova6D. Sherstnev7A. Proydakov8E. Lyurova9T. Pospelova10T. Babaeva11N. Bulieva12G. Kuchma13E. Andreevskaya14M. Frolova15E. Zinina16K. Trizna17I. Shestopalova18T. Shneyder19L. Khvorostenko20A. Kuchin21I. Mulina22S. Volkova23S. Zakharov24N. Porfirieva25T. Nikitina26S. Gritsaev271 Multinational Center for Quality of Life Research, Saint-Petersburg2 Hematology Center of Botkin Hospital, Moscow2 Hematology Center of Botkin Hospital, Moscow2 Hematology Center of Botkin Hospital, Moscow2 Hematology Center of Botkin Hospital, Moscow2 Hematology Center of Botkin Hospital, Moscow3 Saratov State Medical University named after V.I. Razumovsky, Saratov3 Saratov State Medical University named after V.I. Razumovsky, Saratov4 Komi Republican Oncology Center, Syktyvkar4 Komi Republican Oncology Center, Syktyvkar5 Federal State Budgetary Educational Institution of Higher Education «Novosibirsk State Medical University» of the Ministry of Health of the Russian Federation, Novosibirsk5 Federal State Budgetary Educational Institution of Higher Education «Novosibirsk State Medical University» of the Ministry of Health of the Russian Federation, Novosibirsk6 Regional Clinical Hospital of the Kaliningrad Region, Kaliningrad7 Regional Clinical Hospital, Orenburg8 Regional Clinical Hospital №1, Chita9 Regional Hospital № 1, Vologda10 Surgut Regional Clinical Hospital, Surgut11 Regional Clinical Hospital, Tomsk12 Kray Clinical Hospital, Khabarovsk13 Leningrad Regional Clinical Hospital, Saint-Petersburg14 Regional Clinical Hospital, Tyumen’15 Republican Clinical Hospital, Petrozavodsk16 Republican Clinical Hospital №1, Yakutsk17 Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Nizhny Novgorod18 Moscow Regional Research and Clinical Institute (“MONIKI”), Moscow1 Multinational Center for Quality of Life Research, Saint-Petersburg1 Multinational Center for Quality of Life Research, Saint-Petersburg19 Russian Research Institute of Hematology and Transfusiology, Saint-Petersburg, Russiahttp://journals.lww.com/10.1097/01.HS9.0000852060.15771.ed
spellingShingle T. Ionova
O. Vinogradova
E. Markova
L. Mukha
N. Novitskaya
M. Pankrashkina
T. Shelekhova
D. Sherstnev
A. Proydakov
E. Lyurova
T. Pospelova
T. Babaeva
N. Bulieva
G. Kuchma
E. Andreevskaya
M. Frolova
E. Zinina
K. Trizna
I. Shestopalova
T. Shneyder
L. Khvorostenko
A. Kuchin
I. Mulina
S. Volkova
S. Zakharov
N. Porfirieva
T. Nikitina
S. Gritsaev
PB2308: QUALITY OF LIFE AND CLINICAL OUTCOMES IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) DURING TREATMENT WITH ROMIPLOSTIM IN A REAL-WORLD SETTING
HemaSphere
title PB2308: QUALITY OF LIFE AND CLINICAL OUTCOMES IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) DURING TREATMENT WITH ROMIPLOSTIM IN A REAL-WORLD SETTING
title_full PB2308: QUALITY OF LIFE AND CLINICAL OUTCOMES IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) DURING TREATMENT WITH ROMIPLOSTIM IN A REAL-WORLD SETTING
title_fullStr PB2308: QUALITY OF LIFE AND CLINICAL OUTCOMES IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) DURING TREATMENT WITH ROMIPLOSTIM IN A REAL-WORLD SETTING
title_full_unstemmed PB2308: QUALITY OF LIFE AND CLINICAL OUTCOMES IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) DURING TREATMENT WITH ROMIPLOSTIM IN A REAL-WORLD SETTING
title_short PB2308: QUALITY OF LIFE AND CLINICAL OUTCOMES IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (CITP) DURING TREATMENT WITH ROMIPLOSTIM IN A REAL-WORLD SETTING
title_sort pb2308 quality of life and clinical outcomes in adult patients with chronic immune thrombocytopenia citp during treatment with romiplostim in a real world setting
url http://journals.lww.com/10.1097/01.HS9.0000852060.15771.ed
work_keys_str_mv AT tionova pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT ovinogradova pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT emarkova pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT lmukha pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT nnovitskaya pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT mpankrashkina pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT tshelekhova pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT dsherstnev pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT aproydakov pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT elyurova pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT tpospelova pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT tbabaeva pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT nbulieva pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT gkuchma pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT eandreevskaya pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT mfrolova pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT ezinina pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT ktrizna pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT ishestopalova pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT tshneyder pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT lkhvorostenko pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT akuchin pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT imulina pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT svolkova pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT szakharov pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT nporfirieva pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT tnikitina pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting
AT sgritsaev pb2308qualityoflifeandclinicaloutcomesinadultpatientswithchronicimmunethrombocytopeniacitpduringtreatmentwithromiplostiminarealworldsetting